NO20065659L - 3-((4-fenyul)-piperazin-1-yl)-alkyl)-3alkyl-1, 3-dihydro-2H-indol-2-on derivater og relaterte forbindelser for behandling av forstyrrelser i sentralnervesystemet - Google Patents
3-((4-fenyul)-piperazin-1-yl)-alkyl)-3alkyl-1, 3-dihydro-2H-indol-2-on derivater og relaterte forbindelser for behandling av forstyrrelser i sentralnervesystemetInfo
- Publication number
- NO20065659L NO20065659L NO20065659A NO20065659A NO20065659L NO 20065659 L NO20065659 L NO 20065659L NO 20065659 A NO20065659 A NO 20065659A NO 20065659 A NO20065659 A NO 20065659A NO 20065659 L NO20065659 L NO 20065659L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- hydrogen
- halogen
- central nervous
- nervous system
- Prior art date
Links
- -1 (4-Phenyl) -piperazin-1-yl Chemical group 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 208000015114 central nervous system disease Diseases 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 150000002367 halogens Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 210000000748 cardiovascular system Anatomy 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000005095 gastrointestinal system Anatomy 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polyurethanes Or Polyureas (AREA)
Abstract
Det beskrives nye 3,3-disubstituerte indol-2-onderivater med den generelle Formel (I), der R er hydrogen, halogen, C1-7 alkyl eller sulfonamido; R2 er hydrogen eller halogen; R3 er hydrogen eller C1-7- alkyl, eventuelt med en arylsubstituent, eller aryl som eventuelt bærer en eller to halogensubstituenter; R4 er C1-7 alkyl; R5 er en gruppe med den generelle Formel (Ila) eller (Hb), der Q og W hver betyr nitrogen eller CH; R6, R7 og R8 hver er hydrogen, halogen, trifluormetyl, C1-7 alkyl eller -alkoksy, eller R6 og R7 sammen er etylendioksy; m er 0, 1 eller 2; a er en enkelt-, dobbelt- eller trippelbinding; n er 0, 1 eller 2; og farmasøytisk akseptable syreaddisjonssalter derav. Forbindelsen som beskrevet er nyttige ved terapi eller profylakse av sykdommer i forbindelse med sentralnervesystemet, gastrointestinalsystemet og det kardiovaskulære system.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0400957A HU0400957D0 (en) | 2004-05-11 | 2004-05-11 | Piperazinbe derivatives of dialkyl oxindoles |
HU0500464A HUP0500464A3 (en) | 2005-05-05 | 2005-05-05 | Piperazine derivatives of dialkyl-oxindoles |
PCT/HU2005/000052 WO2005109987A2 (en) | 2004-05-11 | 2005-05-11 | 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20065659L true NO20065659L (no) | 2007-01-29 |
Family
ID=89986001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20065659A NO20065659L (no) | 2004-05-11 | 2006-12-06 | 3-((4-fenyul)-piperazin-1-yl)-alkyl)-3alkyl-1, 3-dihydro-2H-indol-2-on derivater og relaterte forbindelser for behandling av forstyrrelser i sentralnervesystemet |
Country Status (24)
Country | Link |
---|---|
US (1) | US7786129B2 (no) |
EP (1) | EP1776339B1 (no) |
JP (1) | JP2007537229A (no) |
KR (1) | KR20070011594A (no) |
AT (1) | ATE435204T1 (no) |
AU (1) | AU2005244389B2 (no) |
BG (1) | BG109771A (no) |
CA (1) | CA2565514A1 (no) |
CZ (1) | CZ2006777A3 (no) |
DE (1) | DE602005015223D1 (no) |
DK (1) | DK1776339T3 (no) |
EA (1) | EA014236B1 (no) |
ES (1) | ES2329388T3 (no) |
HR (2) | HRP20060404A2 (no) |
IL (1) | IL179029A (no) |
MX (1) | MXPA06013069A (no) |
NO (1) | NO20065659L (no) |
NZ (1) | NZ551547A (no) |
PL (1) | PL1776339T3 (no) |
PT (1) | PT1776339E (no) |
RS (1) | RS20060623A (no) |
SI (1) | SI1776339T1 (no) |
SK (1) | SK51072006A3 (no) |
WO (1) | WO2005109987A2 (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2018863B9 (en) | 2006-05-16 | 2015-02-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
EP2789338A3 (en) | 2007-11-15 | 2015-01-14 | Takeda Pharmaceutical Company Limited | Condensed pyridine derivate and use thereof |
HUP0900071A2 (en) * | 2009-02-06 | 2010-10-28 | Egis Gyogyszergyar Nyilvanosan | Optically active 3-[(phenyl-piperazin-1-yl)alkyl]-3-alkyl-oxindole derivatives influencing the central nervous system and pharmaceutical compositions containing them |
JPWO2019131902A1 (ja) | 2017-12-27 | 2020-12-10 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2635104B1 (fr) * | 1988-08-03 | 1992-04-30 | Synthelabo | Derives d'indolone, leur preparation et leur application en therapeutique |
GB8830312D0 (en) * | 1988-12-28 | 1989-02-22 | Lundbeck & Co As H | Heterocyclic compounds |
WO1998008816A1 (fr) * | 1996-08-26 | 1998-03-05 | Meiji Seika Kaisha, Ltd. | Derives d'indoxyle et psychotropes |
CA2564009A1 (en) * | 2004-05-11 | 2005-11-17 | Balazs Volk | Piperazine derivatives of alkyl oxindoles |
KR20070014189A (ko) | 2004-05-11 | 2007-01-31 | 에지스 지오기스제르기아르 엔와이알티. | 중추 신경계 질환, 위장 질환 및 심혈관계 질환 치료용인돌-2-온 유도체 |
-
2005
- 2005-05-11 EA EA200602083A patent/EA014236B1/ru not_active IP Right Cessation
- 2005-05-11 CZ CZ20060777A patent/CZ2006777A3/cs unknown
- 2005-05-11 DE DE602005015223T patent/DE602005015223D1/de active Active
- 2005-05-11 NZ NZ551547A patent/NZ551547A/en unknown
- 2005-05-11 ES ES05779909T patent/ES2329388T3/es active Active
- 2005-05-11 JP JP2007512537A patent/JP2007537229A/ja not_active Ceased
- 2005-05-11 PT PT05779909T patent/PT1776339E/pt unknown
- 2005-05-11 CA CA002565514A patent/CA2565514A1/en not_active Abandoned
- 2005-05-11 MX MXPA06013069A patent/MXPA06013069A/es active IP Right Grant
- 2005-05-11 SK SK5107-2006A patent/SK51072006A3/sk not_active Application Discontinuation
- 2005-05-11 DK DK05779909T patent/DK1776339T3/da active
- 2005-05-11 PL PL05779909T patent/PL1776339T3/pl unknown
- 2005-05-11 SI SI200530785T patent/SI1776339T1/sl unknown
- 2005-05-11 AU AU2005244389A patent/AU2005244389B2/en not_active Ceased
- 2005-05-11 AT AT05779909T patent/ATE435204T1/de active
- 2005-05-11 RS RSP-2006/0623A patent/RS20060623A/sr unknown
- 2005-05-11 US US11/596,473 patent/US7786129B2/en not_active Expired - Fee Related
- 2005-05-11 KR KR1020067026024A patent/KR20070011594A/ko not_active Application Discontinuation
- 2005-05-11 WO PCT/HU2005/000052 patent/WO2005109987A2/en active Application Filing
- 2005-05-11 EP EP05779909A patent/EP1776339B1/en active Active
-
2006
- 2006-11-02 IL IL179029A patent/IL179029A/en not_active IP Right Cessation
- 2006-11-20 HR HR20060404A patent/HRP20060404A2/xx not_active Application Discontinuation
- 2006-12-06 NO NO20065659A patent/NO20065659L/no not_active Application Discontinuation
- 2006-12-11 BG BG109771A patent/BG109771A/bg unknown
-
2009
- 2009-09-22 HR HR20090504T patent/HRP20090504T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
EA200602083A1 (ru) | 2007-06-29 |
SK51072006A3 (sk) | 2007-05-03 |
PL1776339T3 (pl) | 2009-12-31 |
US20070232619A1 (en) | 2007-10-04 |
IL179029A0 (en) | 2007-03-08 |
IL179029A (en) | 2011-11-30 |
JP2007537229A (ja) | 2007-12-20 |
WO2005109987A2 (en) | 2005-11-24 |
EP1776339B1 (en) | 2009-07-01 |
SI1776339T1 (sl) | 2009-12-31 |
CA2565514A1 (en) | 2005-11-24 |
DK1776339T3 (da) | 2009-11-02 |
HRP20060404A2 (en) | 2007-04-30 |
MXPA06013069A (es) | 2007-03-30 |
RS20060623A (en) | 2008-09-29 |
PT1776339E (pt) | 2009-09-16 |
ES2329388T3 (es) | 2009-11-25 |
HRP20090504T1 (hr) | 2009-10-31 |
EA014236B1 (ru) | 2010-10-29 |
WO2005109987A9 (en) | 2007-03-29 |
US7786129B2 (en) | 2010-08-31 |
ATE435204T1 (de) | 2009-07-15 |
DE602005015223D1 (de) | 2009-08-13 |
AU2005244389B2 (en) | 2011-09-01 |
BG109771A (bg) | 2008-05-30 |
NZ551547A (en) | 2010-06-25 |
CZ2006777A3 (cs) | 2007-03-14 |
KR20070011594A (ko) | 2007-01-24 |
AU2005244389A1 (en) | 2005-11-24 |
EP1776339A2 (en) | 2007-04-25 |
WO2005109987A3 (en) | 2006-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062370L (no) | Amidderivater | |
NO20052730L (no) | Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser | |
NO20071140L (no) | Nye piperidinderivater som histamin H3 reseptorligander for behandling av depresjon | |
NO20090216L (no) | Forbindelser med CRTH2 antagonistaktivitet | |
DE60311821D1 (de) | Dibenzylaminverbindung und deren medizinische verwendung | |
NO20064579L (no) | Bifenylforbindelser anvendelige som muskariniske receptorantagonister | |
NO20072833L (no) | Bi- og tricykliske substituterte fenylmetanoner som glycinetransportor I-(Glyt-1)-inhibitorer for behandling av Alzheimers sykdom | |
NO20063382L (no) | Nye kinolinderivater | |
NO20054852L (no) | GFAT inhibitorer | |
EA201000557A1 (ru) | Производные тетрагидрохинолина для лечения посттравматических стрессовых расстройств | |
NO20071137L (no) | Nye piperidinderivater for behandling av depresjon | |
NO20084302L (no) | 2-(syklisk amino)-pyrimidonderivater som TPK1-inhibitorer | |
EA200501585A1 (ru) | Производные азетидинкарбоксамида и их применение при лечении нарушений, опосредованных св1 рецепторами | |
NO20070258L (no) | Benzyltriazolonforbindelser som ikke-nukleoside revers transkriptase inhibitorer | |
NO20063597L (no) | Acetylinske piperazinforbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
NO20065918L (no) | Tetrahydroioskinolonderivater, fremstilling derav og anvendelse som terapeutisk middel | |
NO20054135L (no) | Kipolinon/benzoksazin derivater og anvendelser derav | |
NO20071008L (no) | Fremgangsmate for fremstilling av N-piperidino-1,5-difenylpyrazol-3-karboksamidderivater | |
NO20080394L (no) | N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav | |
AR040489A1 (es) | Compuestos derivados de 3-fenil-propionamido, 3-fenil-acrilamido y 3-fenil-propinamido, su uso para la elaboracion de medicamentos, un proceso para elaborar los compuestos y medicamentos que los contienen | |
NO984761L (no) | Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler | |
ATE396183T1 (de) | Chromanderivate und ihre verwendung als liganden des 5-ht-rezeptors | |
NO20070789L (no) | Nikotinreseptoragonister for behandling av betennelsessykdommer | |
NO20065659L (no) | 3-((4-fenyul)-piperazin-1-yl)-alkyl)-3alkyl-1, 3-dihydro-2H-indol-2-on derivater og relaterte forbindelser for behandling av forstyrrelser i sentralnervesystemet | |
NO20083917L (no) | Malonamidderivater som gammasekretaseinhibitorer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |